Evolv Technologies Holdings, Inc. (EVLV) stock
Close on Nov 17, 2026Market cap $700.96MP/E –Yield –
Earnings
Evolv Technologies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Evolv Technologies's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 9, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 10, 2026after the close | $47.30M | +10.3% | -$0.09 | -$0.02 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 11, 2026after the close | $43.80M | +34.8% | -$0.05 | -$0.02 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 12, 2026after the close | $46.30M | +44.7% | -$0.03 | -$0.02 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 10, 2026after the close | $38.50M | – | $0.06 | -$0.03 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 13, 2025after the close | $42.90M | – | -$0.01 | -$0.02 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 14, 2025after the close | $32.50M | +27.5% | -$0.25 | -$0.02 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 20, 2025after the close | $32.00M | +47.5% | -$0.01 | -$0.02 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 23, 2025before the open | – | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024after the close | $25.50M | +28.8% | $0.02 | -$0.06 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024after the close | $21.70M | +16.7% | -$0.08 | -$0.09 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 29, 2024after the close | $21.80M | +4.3% | -$0.11 | -$0.07 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 12, 2023before the open | – | – | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 10, 2023after the close | $19.80M | +117.6% | -$0.45 | -$0.10 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 10, 2023after the close | $18.60M | +113.8% | -$0.20 | -$0.12 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 1, 2023after the close | $20.90M | +207.4% | -$0.19 | -$0.12 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 9, 2022after the close | $16.50M | +96.4% | -$0.13 | -$0.13 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 10, 2022after the close | $9.10M | – | -$0.18 | -$0.12 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 11, 2022after the close | $8.70M | – | -$0.10 | -$0.13 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 14, 2022after the close | $6.80M | – | $0.02 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 10, 2021after the close | $8.40M | – | $0.15 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 16, 2021after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Evolv Technologies's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenueGAAP | FY2026 | $182.00M – $185.00M | – | New | Nov 10, 2026 |
| total revenues | FY2026 | $180.00M – $185.00M | $175.00M – $180.00M | Raised | Aug 11, 2026 |
| total revenues growth | FY2026 | +23% – +27% | +20% – +23% | Raised | Aug 11, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $15.50M – $16.50M | – | New | Nov 10, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $15.00M – $16.00M | – | New | Aug 11, 2026 |
| ending ARRnon-GAAP | FY2026 | $148.00M – $150.00M | – | New | Nov 10, 2026 |
| ending ARR | FY2026 | $145.00M – $150.00M | $145.00M – $150.00M | Reaffirmed | May 12, 2026 |
| ending ARR growth | FY2026 | +20% – +25% | +20% – +25% | Reaffirmed | May 12, 2026 |
Guidance vs results
The last range Evolv Technologies gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $142.00M – $145.00M | $145.90MΣ4Q | Above range |
Guidance history
Every forecast Evolv Technologies put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 10, 2026 | Adjusted EBITDA | FY2026 | $15.50M – $16.50M | New |
| Nov 10, 2026 | ending ARR | FY2026 | $148.00M – $150.00M | New |
| Nov 10, 2026 | revenue | FY2026 | $182.00M – $185.00M | New |
| Aug 11, 2026 | Adjusted EBITDA | FY2026 | $15.00M – $16.00M | New |
| Aug 11, 2026 | total revenues growth | FY2026 | +23% – +27% | Raised |
| Aug 11, 2026 | total revenues | FY2026 | $180.00M – $185.00M | Raised |
| May 12, 2026 | ending ARR growth | FY2026 | +20% – +25% | Reaffirmed |
| May 12, 2026 | ending ARR | FY2026 | $145.00M – $150.00M | Reaffirmed |
| May 12, 2026 | total revenues growth | FY2026 | +20% – +23% | Raised |
| May 12, 2026 | total revenues | FY2026 | $175.00M – $180.00M | Raised |
| Mar 10, 2026 | ending ARR growth | FY2026 | +20% – +25% | New |
| Mar 10, 2026 | ending ARR | FY2026 | $145.00M – $150.00M | New |
| Mar 10, 2026 | total revenues growth | FY2026 | +18% – +22% | New |
| Mar 10, 2026 | total revenues | FY2026 | $172.00M – $178.00M | New |
| Nov 13, 2025 | growth | FY2025 | +37% – +40% | New |
| Nov 13, 2025 | total revenues | FY2025 | $142.00M – $145.00M | New |
| Aug 14, 2025 | growth | FY2025 | +27% – +30% | New |
| Aug 14, 2025 | total revenues | FY2025 | $132.00M – $135.00M | Raised |
| May 20, 2025 | total revenues | FY2025 | $125.00M – $130.00M | New |
| Aug 8, 2024 | Adjusted Gross Margin | FY2024 | 60% | Reaffirmed |
| Aug 8, 2024 | Total Revenue | FY2024 | $100.00M | New |
| May 9, 2024 | Adjusted EBITDA 3 | FY2024 | +40% | New |
| May 9, 2024 | Adjusted Gross Margin 3 | FY2024 | 60% | New |
| May 9, 2024 | ARR 1 (ARR) at 12/31/24 | FY2024 | $100.00M | New |
| May 9, 2024 | Total Revenue | FY2024 | $100.00M | New |
| Oct 12, 2023 | Adjusted EBITDA 2 | FY2023 | -$53.00M – -$50.00M | Raised |
| Oct 12, 2023 | Adjusted Gross Margin 2 | FY2023 | 43% – 45% | Raised |
| Oct 12, 2023 | Annual Recurring Revenue 1 (ARR) at 12/31/23 | FY2023 | $73.00M – $75.00M | Raised |
| Oct 12, 2023 | Total Revenue | FY2023 | $75.00M – $77.00M | New |
| Aug 10, 2023 | Adjusted EBITDA 3 | FY2023 | -$56.00M – -$52.00M | Raised |
| Aug 10, 2023 | Adjusted Gross Margin 3 | FY2023 | 38% – 42% | Raised |
| Aug 10, 2023 | Annual Recurring Revenue 1 (ARR) at 12/31/23 | FY2023 | $70.00M – $72.00M | Raised |
| Aug 10, 2023 | Total Revenue | FY2023 | $70.00M – $75.00M | Raised |
| May 10, 2023 | Adjusted EBITDA 3 | FY2023 | -$58.00M – -$53.00M | Raised |
| May 10, 2023 | Adjusted Gross Margin 3 | FY2023 | 35% – 40% | New |
| May 10, 2023 | Annual Recurring Revenue 1 (ARR) at 12/31/23 | FY2023 | $67.00M – $71.00M | Raised |
| May 10, 2023 | Total Revenue | FY2023 | $60.00M – $65.00M | Raised |
| Mar 1, 2023 | Adjusted EBITDA | FY2023 | -$60.00M – -$55.00M | New |
| Mar 1, 2023 | Annual Recurring Revenue 1 (ARR) at 12/31/23 | FY2023 | $65.00M – $70.00M | Reaffirmed |
| Mar 1, 2023 | Cash and Cash Equivalents | FY2023 | $165.00M – $175.00M | New |
| Mar 1, 2023 | Total Revenue | FY2023 | $55.00M – $60.00M | Reaffirmed |
| Nov 9, 2022 | Adjusted EBITDA | FY2022 | -$67.00M – -$65.00M | Reaffirmed |
| Nov 9, 2022 | Annual Recurring Revenue 3 (ARR) at 12/31 | FY2022 | $31.00M – $32.00M | Raised |
| Nov 9, 2022 | Cash and Cash Equivalents | FY2022 | $220.00M – $230.00M | Raised |
| Nov 9, 2022 | exiting ARR | FY2023 | $65.00M – $70.00M | New |
| Nov 9, 2022 | Total Revenue | FY2022 | $46.00M – $48.00M | Raised |
| Nov 9, 2022 | full year revenues | FY2023 | $55.00M – $60.00M | New |
| Aug 10, 2022 | Adjusted EBITDA | FY2022 | -$67.00M – -$65.00M | Reaffirmed |
| Aug 10, 2022 | Annual Recurring Revenue 3 (ARR) at 12/31 | FY2022 | $27.00M – $28.00M | Reaffirmed |
| Aug 10, 2022 | Cash and Cash Equivalents | FY2022 | $220.00M – $230.00M | Reaffirmed |
| Aug 10, 2022 | Total Revenue | FY2022 | $29.00M – $31.00M | Reaffirmed |
| May 11, 2022 | Adjusted EBITDA 3 | FY2022 | -$67.00M – -$65.00M | Reaffirmed |
| May 11, 2022 | Cash and Cash Equivalents | FY2022 | $220.00M – $230.00M | Reaffirmed |
| May 11, 2022 | Annual Recurring Revenue 2 (ARR) at 12/31 | FY2022 | $27.00M – $28.00M | New |
| May 11, 2022 | Total Revenue | FY2022 | $29.00M – $31.00M | Reaffirmed |
| Mar 14, 2022 | Adjusted EBITDA 4 | FY2022 | -$67.00M – -$65.00M | New |
| Mar 14, 2022 | Operating Loss | FY2022 | -$84.00M – -$82.00M | New |
| Mar 14, 2022 | Annual Recurring Revenue 3 at 12/31 | FY2022 | $27.00M – $28.00M | New |
| Mar 14, 2022 | Operating Expenses | FY2022 | $94.00M – $96.00M | New |
| Mar 14, 2022 | Cash and Cash Equivalents | FY2022 | $220.00M – $230.00M | Raised |
| Mar 14, 2022 | Total Revenue | FY2022 | $29.00M – $31.00M | New |
| Nov 10, 2021 | TCV of orders booked | FY2021 | $53.00M – $57.00M | New |
| Nov 10, 2021 | Total Revenue | FY2021 | $20.00M – $23.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Evolv Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- News
- News
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Update
- Update
- Update
See a number that looks wrong?